FLAG Therapeutics

FLAG Therapeutics is a clinical-stage company developing small molecule therapeutics for difficult-to-treat cancers. FLAG's lead cadidate targets glioblastoma multiform and Diffuse Intrinsic Pontine Glioma and has received an FDA Rare Pediatric Drug designation.